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The Pattern of Ectopic Hormone Production
in Lung Cancer
PHILIP K. BONDY, M.D.
West Haven V.A. Medical Center, West Haven, Connecticut, andthe Department of
Internal Medicine, Yale University School ofMedicine, New Haven, Connecticut
Pulmonary cancers produce many hormonal polypeptides. There is a tumor-specific pattern
to the appearance of abnormal adrenal function and inappropriate secretion of vasopressin,
which are frequently found in small cell undifferentiated carcinoma but occur only very rarely,
if at all, in squamous tumors. Humoral hypercalcemia, on the other hand, occurs almost
entirely in squamous tumors and is rarely if ever seen in small cell or large cell tumors or in
adenocarcinoma. In contrast, "big ACTH" and beta lipotropin are found in the plasma and
tumor extracts of lung cancers of all types. Calcitonin and the beta chain of human chorionic
gonadotropin are also found in the plasma of a considerable portion of patients with all
histological types of lung cancers.
The association of certain pulmonary neoplasms with hormonal syndromes has
been recognized for at least 50 years [1], and thefact that such syndromes result from
release of polypeptide hormones by the tumor has been known for at least two
decades [2,3]. The fact that the hormones originate in tumors arising in tissue which
does not usually secrete endocrine substances led to their being called "ectopic" [4].
Since the discovery of this property of tumors, an immense literature has built up,
reporting individuals or small groups of patients with the syndromes produced by
ectopic hormones. Within the past five years or less, the possibility of utilizing the
production of such hormones as markers in diagnosing pulmonary tumors and
following their response to treatment has led to active interest in the levels of these
substances in the plasma of patients with pulmonary neoplasms. It is somewhat
surprising, therefore, that very few studies have been published in which an attempt
has been made to study populations ofpatients with carcinoma ofthe lungin order to
determine the distribution and frequency of the production of hormones by tumors
of various types. In this paper an attempt is made to survey the present state ofthe
problem in order to determine whether there is a characteristic distribution pattern of
hormones produced by lung tumors according to their histological classification. The
question of whether measurement of such hormones is helpful in following the
clinical course of the patients will not be discussed, since it has been considered
elsewhere [5,6].
The literature was surveyed for studies in which an attempt had been made to
investigate all patients with carcinoma of the lung entering the clinic or hospital. In
some instances, the survey was limited to a particular type of tumor (usually small
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All rights of reproduction in any form rescrved.cell undifferentiated carcinoma) and these were accepted provided itappeared that all
patients with the diagnosis had been included. Reports were rejected if the authors
had investigated only or chiefly patients with clinical endocrine syndromes, or if the
histological classification of the patients was not indicated.
In many instances the survey was limited to measurement of plasma hormones by
radioimmuno- or bioassay, but in others physiological investigations were also used
to seek evidence for abnormal control of such variables as plasma cortisol, serum
calcium concentration and plasma, and urine osmolality or urine volume. The
diagnosis of abnormal adrenal cortical control was based on loss ofdiurnal variation
or suppressibility of plasma cortisol concentration with dexamethasone. The diagno-
sis of SIADH was based on hemodilution combined with high urinary osmolality.
The results are shown in the tables. Table 1 shows the frequency with which
abnormalities of adrenal function, vasopressin secretion, calcium concentration,
plasma calcitonin, and beta HCG were observed in each histological type of tumor.
Note that abnormal adrenal function and SIADH were observed very frequently in
small cell tumors and never in squamous tumors, whereas hypercalcemia was
common in squamous but absent in small cell neoplasms. Calcitonin and hCG were
often increased in all types of tumors.
Ever since the work of Gerwirtz and Yalow [8] there has been interest in whether
metabolic precursors of ACTH such as "big" ACTH or beta lipotropin might be
useful as tumor markers. Table 2 shows the results of studies using the special
methods necessary for detection of these moieties. Because Yalow's group has been
interested in comparing tumor and plasma levels, they have not studied many
patients with small cell tumors. Surgery is seldom performed in this group, so tissue
adequate for measuring tumor hormone concentration is seldom available. The
limited number of small cell tumors reported in the table reflects this research
strategy [9].
Table 1 probably presents a minimal value for the incidence of the abnormalities
mentioned, because most surveys obtained their data on only one occasionduring the
patients' course. An abnormality developing at some other time during the disease
might therefore have been missed. Moreover, some abnormalities are demonstrable
only after tests which stress or manipulate the system under study. For example, the
incidence of the syndrome of inappropriate vasopressin secretion (SIADH) may
become apparent only when a patient with mildly depressed plasma osmolality is
subjected to a water load [12]. Surveys dependingentirely on a single measurement of
ACTH concentration may be misleading. It is well known that the plasma ACTH
normally varies rapidly over a wide range, so even in a patient ordinarily having a
slightly elevated hormone concentration it is possible that a single determination
might fall within the normal range. Moreover, if a substantial portion of the
circulating ACTH originates in the tumor, the normal control mechanisms producing
diurnal rhythmicity and feedback suppression might be lost although total ACTH is
within normal limits [11,12]. ACTH samples obtained late in the day should have a
higher discriminating value than those taken early in the morning because ofdiurnal
variation of normal pituitary secretion of ACTH, but Yalow's group [9] seems to be
the only one taking advantage of this fact.
Experienced pathologists often disagree in classifying tumors, especially when the
specimen contains more than one type of tissue. The differentiation of a highly
anaplastic squamous tumor from a small cell cancer may occasionally depend on the
presence of only a few strands of keratin. Whether such a tumor ends up in the small
cell or squamous category depends to some extent on whether the pathologist bases
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TABLE 2
"Big" ACTH and beta LPH as Markers of Lung Cancer
ACTH > 100 pg/ml beta LPH > 60 pg/ml
No. No. % No. No. To
Cell Type positive examined positive positive examined positive
Small Cell 17 27 63 13 24 54
Squamous 79 86 92 10 30 33
Adenocarcinoma 32 40 80 20 20 100
Large Cell 7 11 64
Source: [9,11,27]
his classification on the most differentiated portion of the tumor or on the average
appearance. Electron microscopy may be valuable in identifying the "APUD" cells
which produce the small cell secretory pattern[23], but most authors did not mention
using this modality.
Considering these problems, it is interesting that the histological classification of
types of pulmonary neoplasms in several different clinical centers produced such a
clear pattern of association of abnormal adrenal control, SIADH, and humoral
hypercalcemia with specific types of tumors. It appears that these three determina-
tions can discriminate between small cell and squamous tumors, and could be used to
bolster a diagnosis based on histology or to predict the histology (and therefore the
response to treatment) if tissue is not available. The hormones appear to be of less
differential value in adenocarcinoma, but the number of observations is small.
Calcitonin is not of much value in differential diagnosis, although it has been
recommended for following the response to treatment [6]. It should also be remem-
bered that many of these hormones may be increased for other causes than secretion
by the tumor. SIADH can be caused by nonmalignant disease ofthe lungs, especially
infection [24] and ACTH is secreted in response to a variety of stresses [25].
There is general agreement that in patients with carcinoma of the lung the
syndrome of ectopic ACTH production occurs mainly, if not uniquely, in small cell
tumors. The data in Table 2 are interesting, therefore, because they suggest that all
lung tumors contain and may release a non-functional form ofACTH, which may be
a pro-ACTH ("big" ACTH) or the larger precursor polypeptide, beta lipotropin. This
polypeptide includes ACTH in its amino acid sequence together with the endorphins
and melanocyte stimulating activity. Aside from its ability to produce darkening of
the skin, beta lipotropin is not known to have any physiological activity, in spite of
the powerful effects produced by its fragments. It is possible that most lung tumors
can produce the precursor but only the small cell tumor can break it down to
functional units [26]. In any case, there is a clear clinical difference between the
probable diagnosis of small cell tumor in the presence of an abnormality ofadrenal
function and the demonstration of some form of "big" ACTH or beta lipotropin
[9,11,27] in the plasma of patients with lung tumors regardless of histological type.
The general presence of"big" ACTH in all types of lung cancer is reminiscent of the
beta chain of human chorionic gonadotropin, which has been found in an ineffective
form in normal tissue and most tumors [29] and may therefore be of some value in
diagnosing cancer, but not in distinguishing one tumor from another.
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